Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Genzyme Corp. (NASDAQ:

* Reuters is not responsible for the content in this press release.

Thu Jul 30, 2009 3:14pm EDT

  OKLAHOMA CITY, OK, Jul 30 (MARKET WIRE) -- 
On July 29, 2009, a class action lawsuit was filed in the United States
District Court for the District of Massachusetts against Genzyme Corp.
(NASDAQ: GENZ). The complaint alleges violations of federal securities
laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and
Rule 10b-5, including allegations of issuing a series of material
misrepresentations to the market which had the effect of artificially
inflating the market price. The class period is from June 26, 2008
through July 21, 2009.

    Plaintiff seeks to recover damages on behalf of the Class. If you are a
member of the Class as described above, you may move the Court no later
than Monday, September 28, 2009, to serve as a lead plaintiff for the
Class. However, in order to do so, you must meet certain legal
requirements pursuant to the Private Securities Litigation Reform Act of
1995.

    If you wish to discuss this action, participate in this or any other
lawsuit, or have any questions or concerns regarding this notice, or
preservation of your rights, please contact:

    

K. Lynn Nunn
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: kln@federmanlaw.com
www.federmanlaw.com

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.